Hemodialysis and peritoneal dialysis patients are more likely than non-dialysis patients to suffer an ischemic or hemorrhagic stroke.
Starting dialysis after conception, not before, may improve birth rates in women with end-stage renal disease.
Receiving nocturnal dialysis may decrease the risk of heart disease in patients with end-stage renal disease.
Shorter survival found among patients who had intensive procedures and started dialysis in the hospital.
Common genetic polymorphisms may explain patterns in vitamin D status in blacks.
Behavioral therapy provided chair-side to kidney failure patients while they are undergoing dialysis may help fight depression.
Agency releases a video, a poster, and a pocket guide to help providers and patients prevent development of infectious complications in patients undergoing hemodialysis.
Elemental iron requirement was reduced by half in patients receiving ferric citrate versus an active control.
New findings are based on a study of 472 patients with stage 4-5 chronic kidney disease.
Weekly dose of erythropoiesis-stimulating agents decreased and hemoglobin levels increased.
Their presence is associated with a greater than threefold increased risk.
A transferrin saturation of 20% or less was associated with a 2.2 times increased risk of death from any cause.
Study also documents use of higher IV iron doses and declining hemoglobin levels.
Results show an increased risk of mortality and hospitalizations compared with late starts.
Low phosphorus increases all-cause and cardiovascular mortality only among the elderly.
They have a higher inpatient mortality risk and longer lengths of stay compared with those admitted on weekdays.
Over the past 10 years the annual ESRD incidence rate per million U.S. population has remained stagnant or even shown sporadic downward trends.
A new analysis has concluded that large numbers of dialysis patients are inappropriately being prescribed statins to lower their cholesterol.
Dialysis centers are reimbursed a flat amount to cover almost all the costs of providing care to dialysis patients.
Researchers report that elderly end-stage renal disease patients using catheters for dialysis may have the highest risk of dying prematurely.
Prospective randomized study finds no difference in in-hospital mortality and dialysis dependence at three months compared with usual-start dialysis.
Investigators at Duke University have developed a bioengineered blood vessel and successfully implanted it in a dialysis patient.
The dialysis population has a high burden of comorbidities.
The Mediterranean diet is getting more attention because of its long-term benefits in terms of overall mortality and CVD risk.
Use of the agents is associated with a 29% and 22% decreased risk of all-cause and cardiovascular mortality.
The benefits of omega-3 (n-3) fatty acids in renal populations were last discussed in this column in 2007.
Boosting PD use in the U.S. to 12% of dialysis patients from the current 7% would save about $300 million a year, researcher says.
Researchers report that fish oil may protect dialysis patients from sudden cardiac death.
Zinc supplementation has been shown to decrease levels of plasma aluminum and reactive oxygen species in dialysis patients.
Patients' one-year survival expectations more accurate than that of their nephrologist